Disseminated skin rash and blood eosinophilia in a Polish traveler diagnosed Strongyloides stercoralis, Trichuris trichiura, Schistosoma sp. and Blastocystis sp. coinfection

• Autorzy: Pielok L. , Frackowiak K. , Kludkowska M.
• Języki publikacji: EN

Abstrakty

EN

Traveling to tropical countries make very often for travelers a danger of illnesses, which do not exist or exist very rarely in temperate climate. Imported parasitic disease cases are inevitable and have been reported increasingly as a result of enhanced globalization. The most common infections in endemic areas are caused by soil transmitted helminths. Symptoms of many invasions occurred even several weeks after returning from endemic areas (schistosomatosis, strongyloidosis, leishmaniosis). In this work we described a case of a young Polish traveler, who came back to Poland, from two months touristic journey in Democratic Republic of the Congo, Africa, who was diagnosed Schistosoma sp., Trichuris trichiura, Strongyloides stercoralis and Blastocystis sp. coinfection. Parasitic infections should be taken under consideration in differential diagnosis in patients suffering from disseminated skin changes and eosinophilia syndrome specially in individuals returning from endemic areas.

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2019
• Tom: 65
• Numer: 1
• Opis fizyczny: p.99-102,fig.,ref.

Twórcy

autor

Pielok L.

• Department of Tropical and Parasitic Diseases, Karol Marcinkowski University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznan, Poland

autor

Frackowiak K.

• Central Microbiology Laboratory, Heliodor Swiecicki University Hospital, Przybyszewskiego 49, 60-355 Poznan, Poland

autor

Kludkowska M.

• Central Microbiology Laboratory, Heliodor Swiecicki University Hospital, Przybyszewskiego 49, 60-355 Poznan, Poland

Bibliografia

• [1] Angelo T., Buze J, Kinunghi SM. 2018. Geographical and behavioral risk associated with Schistosoma haematobium infection in an area of complex transmission Parasites and Vectors 11: 481. doi:10.1186/s13071-018-3064-5
• [2] Ishida K., Hsiek MH. 2018. Understanding urogenital Schistosomiasis-related bladder cancer: An update. Frontiers in Medicine (Lausanne) 5: 223. doi:10.3389/fmed 2018.00223
• [3] Hajjar W.M., Alsheikh A.M., Alhumaid Y.U. 2018. Pulmonary schistosomiasis in a young male. A case report and review of the literature. Annals of Thoracic Medicine 13: 180-192. doi:10.4103/atm.ATM_300_17
• [4] Myint A., Chapman C., Almira-Suarez J., Mekta N. 2017. Strongyloides hyperinfection syndrome in an immunocompetent host resulting in bandemi and death. BMJ Case Reports 2017. http://dx.doi.org/10.1136/bcr-2016-217911
• [5] Pawłowski Z.S. 2004. Badania laboratoryjne w parazytologii. Parazytologia kliniczna w ujęciu dyscyplinarnym, PZWL (in Polish).
• [6] Martinez-Perez A., Roure-Dier S., Bethassen-Garua M. et al. 2018. Management of severe strongyloidiasis attended at reference centers in Spain, PLOS Neglected Tropical Diseases 12: e0006272. https://doi.org/10.1371/journal.pntd.0006272
• [7] Ardic N. 2009. An overview of Strongyloides stercoralis and its infections. Mikrobiyoloji Bulteni 43: 169-177.
• [8] Caraballo L., Coronada S. 2018. Parasite allergens. Molecular Immunology 100: 113-119. https://doi.org/10.1016/j.molimm.2018.03.014
• [9] Duguenne J., Mabalukwe J., Clavo E., Michaux C., Staub T. 2018. A disseminated strongyloidosis in a non immunocompromised patient. Revue Medicale de Liege 73: 383-386.
• [10] Wang X., Fu Q., Song R. 2018. Antinuclear antibodies and interleukin responses in patients with Schistosoma japonicum infections. Parasite Immunology 40: e12577. doi:10.1111/pim12577
• [11] Gonzalez A., Gallo M., Valls M.E. et al. 2010. Clinical and epidemiological features of 33 imported Strongyloides stercoralis infections. Transactions of The Royal Society of Tropical Medicine and Hygiene 104: 613-616.
• [12] Jagadeesan R., Jain R., Karnik T., Sudararajan T., Ardesonov Z., Sidorenko E. 2018. Strongyloides duodenitis in an immunosupressed patient with Lupus Nephritis. Kansas Journal of Medicine 11: 8-10.
• [13] Overbosch F.W., van God T., Matser A., Sonder G.J.B. 2018. Low incidence helminth infections (schistosomiasis, strongyloidiasis, filariasis, toxocariasis) among Dutch long-term travelers: A prospective study, 2008-2011. PLOS ONE 30: e019770.
• [14] Akiyama M.J., Brown J.D. 2018. Human strongyloidiasis in Hawaii: A retrospective review of Enzyme Linked Immunosorbent Assay Sero diagnostic Testing. The American Journal of Tropical Medici ne and Hygiene (99/2): 370-374. doi:10.4269/ajtmh.18-0157
• [15] Yamanashi H., Kambara S., Murasa K., Maede T. 2018. Eosinophilia, a marker of asymptomatic Strongyloides infection in a young patient with extrapulmonary tuberculoisis. BMJ Case Reports 42018 pii:2017-223208.
• [16] Segarra-Nenham H. 2007. Manifestations, diagnosis and treatment of Strongyloides stercoralis infection. Annals of Pharmacotherapy 41:1992-2001.
• [17] Suzuki Y., Nakamura T., Tokoro M., Togano T. et al. 2010. A case of giardiasis expressing severe systemic symptoms and marked hypereosinophilia, Parasitology International 59: 487-489. https://doi.org/10.1016/j.parint.2010.06.006
• [18] Osiro S., Hamula C., Glaser A., Roma M., Dunn D., 2018. A case of Strongyloides hyperinfection syndrome in the setting of persistent eosinophilia but negative serology, Diagnostic Microbiology and Infectious Diseases 88: 168-170. https://doi.org/10.1016/j.diagmicrobio.2017.02.016
• [19] Magill A.J., Ryan E.T., Hill D.R., Solomon T. 2013. Hunter’s tropical medicine and emerging infectious diseases. Elsevier, 9th ed.

Identyfikatory

DOI

10.17420/ap6501.188